The CCTS Community Collaboration and Engagement Team supports researchers’ engagement and collaboration with community members, patients, and other stakeholders. To address the need for social distancing due to COVID-19, the Team has successfully moved our Engagement Studios and Community Advisory Boards - formerly held in-person - to Zoom. This has enabled research to move forward in spite of the pandemic. ... Read MoreSelect...
Clinical Trials Support Foundation for Discovery
Population Health Foundation for Discovery
Precision Medicine Foundation for Discovery
Workforce Development Foundation for Discovery
COVID-19 is a pandemic turning our world upside down. Utah CCTS wants to halt the effects of this virus and the first step is to conduct research. Researchers and future research volunteers can find resources at the Office of Research Participant Advocacy.
View the COVID-19 research REDCap survey report
Listen to Dr. Emily Spivak discuss COVID-19 on KSL News Radio's Coronavirus Q&A
Watch Dr. Rachel Hess' FB Live interview with Silicon Slopes about the hydroxychloroquine trials
What is the Center for Clinical and Translational Science (CCTS)?
The CCTS is the home for clinical and translational science in our institutions, the state of Utah, and within the Mountain West Region. It builds on our strengths in genetics and bioinformatics to translate promising bench science into practices that improve human health.
The center serves as an academic home for clinical and translational research, developing innovative health services for the community and health researchers, and training a new generation of clinical and translational investigators. Four foundations of discovery compose the center: Clinical Trials Support, Population Health, Precision Medicine, and Workforce Development, and these foundations provide support for T1 to T4 research.
HEAL PAIN ERN - FUNDING ANNOUNCEMENT
FOA Publication Date: January 21, 2020
Earliest Submission: February 24, 2020
Submission Deadline: March 24, 2020
The National Center for Advancing Translational Science (NCATS) is again collaborating on a trans-NIH initiative. A re-issuance of the funding opportunity announcement RFA-NS-19-021 was recently published to solicit applications for clinical trial planning and implementation to generate evidence-based pain management best practices for the use of existing medications or devices for specific pain conditions.
RFA-NS-20-028 is the funding announcement for the HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) and is prioritizing the following areas of interest to generate evidence-based pain management best practices for the use of existing medications or devices for specific pain conditions. The guidelines should be of use to providers in primary care, emergency departments, dental clinics, and hospital settings. The pain conditions of high priority are:
- pain management in emergency departments, dental clinics, primary care and hospitals;
- chronic overlapping pain conditions;
- best practices for effective analgesics when appropriate;
- pain management in individuals at risk of or with OUD;
- pain management in those with co-occurring mental health disorders; and
- Non cancer pain management in persons with medical comorbidities
For more information, please contact Emily.A.Campbell@hsc.utah.edu
Latest NewsMore News
The University of Utah has awarded $1.3 million in seed grants to 56 cross-campus projects that will examine a host of issues arising out of the COVID-19 pandemic. ... Read More
To hasten a response to the COVID-19 pandemic, the University of Utah Office of Research Participant Advocacy is matching volunteers from the general public with research studies. ... Read More
Researchers from University of Utah Health and Intermountain Healthcare in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs – hydroxychloroquine (HCQ) and azithromycin – to treat patients with COVID-19 (infection with the novel coronavirus).... Read MoreInternal Medicine,Population Health Sciences
Beginning in January 2020, clinical research teams will begin reporting accrual data in uTRAC. This will apply to all IRB approved projects that meet the NIH definition of a clinical trial regardless of funding source (see weblink further below to determine if your study is applicable). Study teams from Pediatrics and Internal Medicine have successfully piloted this system over the last year. Early adoption is encouraged. ... Read MoreSelect...
A goal of advancing knowledge and transforming clinical practice.... Read More